Yang Sheng, deputy director of the State Drug Administration, said at the press conference of the State Drug Administration that he supports upgrading the quality of generic drugs, encourages the adoption of advanced international technology and technology, promotes the transformation of generic drugs to high added value and high technical content, improves the overall quality of drug supply, and allows ordinary people to use more good drugs and safe medicines.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.